JP2023145544A5 - - Google Patents

Download PDF

Info

Publication number
JP2023145544A5
JP2023145544A5 JP2023116635A JP2023116635A JP2023145544A5 JP 2023145544 A5 JP2023145544 A5 JP 2023145544A5 JP 2023116635 A JP2023116635 A JP 2023116635A JP 2023116635 A JP2023116635 A JP 2023116635A JP 2023145544 A5 JP2023145544 A5 JP 2023145544A5
Authority
JP
Japan
Prior art keywords
mkp
pharmaceutical composition
group
optionally substituted
disorder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023116635A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023145544A (ja
JP7676477B2 (ja
Filing date
Publication date
Priority claimed from PCT/US2018/066191 external-priority patent/WO2019126141A1/en
Application filed filed Critical
Publication of JP2023145544A publication Critical patent/JP2023145544A/ja
Publication of JP2023145544A5 publication Critical patent/JP2023145544A5/ja
Application granted granted Critical
Publication of JP7676477B2 publication Critical patent/JP7676477B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023116635A 2017-12-18 2023-07-18 線維症を処置するための化合物および組成物 Active JP7676477B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201762607110P 2017-12-18 2017-12-18
US62/607,110 2017-12-18
PCT/US2018/066191 WO2019126141A1 (en) 2017-12-18 2018-12-18 Compounds and compositions for treating fibrosis
JP2020552690A JP7317039B2 (ja) 2017-12-18 2018-12-18 線維症を処置するための化合物および組成物

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2020552690A Division JP7317039B2 (ja) 2017-12-18 2018-12-18 線維症を処置するための化合物および組成物

Publications (3)

Publication Number Publication Date
JP2023145544A JP2023145544A (ja) 2023-10-11
JP2023145544A5 true JP2023145544A5 (https=) 2024-04-10
JP7676477B2 JP7676477B2 (ja) 2025-05-14

Family

ID=66993802

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020552690A Active JP7317039B2 (ja) 2017-12-18 2018-12-18 線維症を処置するための化合物および組成物
JP2023116635A Active JP7676477B2 (ja) 2017-12-18 2023-07-18 線維症を処置するための化合物および組成物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2020552690A Active JP7317039B2 (ja) 2017-12-18 2018-12-18 線維症を処置するための化合物および組成物

Country Status (9)

Country Link
US (3) US11504373B2 (https=)
EP (1) EP3732179B1 (https=)
JP (2) JP7317039B2 (https=)
KR (1) KR20200100726A (https=)
CN (2) CN116687934A (https=)
AU (3) AU2018388549B2 (https=)
CA (1) CA3085770A1 (https=)
MX (2) MX2020006398A (https=)
WO (1) WO2019126141A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2018388549B2 (en) * 2017-12-18 2023-06-01 Yale University Compounds and compositions for treating fibrosis
US12570670B2 (en) * 2019-01-30 2026-03-10 Yale University Compounds, compositions, and methods for treating fibrosis

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040086859A1 (en) 2000-04-10 2004-05-06 Klaus Ducker Identification of a dual specificity phosphate: dusp-10
DE60125783T2 (de) * 2000-08-11 2007-10-18 Evotec Ag Verfahren zum nachweis von acetylase oder deacetylase-aktivität in einem immunoassay
US20030162230A1 (en) * 2000-09-27 2003-08-28 Reagan Kevin J. Method for quantifying phosphokinase activity on proteins
JP2007518702A (ja) * 2003-11-25 2007-07-12 ノバルティス アクチエンゲゼルシャフト ソマトスタチン類似体処置の効力についてのバイオマーカー
US8546410B2 (en) 2008-05-05 2013-10-01 Abbvie Inc. Heteroaryl-fused macrocyclic pyrimidine derivatives
EP2351571A4 (en) * 2008-10-09 2012-08-01 Lsip Llc PROTEINPHOSPHATASEHEMMER
CA2944198C (en) 2013-04-26 2021-11-16 Indiana University Research & Technology Corporation Hydroxyindole carboxylic acid based inhibitors for oncogenic src homology-2 domain containing protein tyrosine phosphatase-2 (shp2)
AU2018388549B2 (en) * 2017-12-18 2023-06-01 Yale University Compounds and compositions for treating fibrosis

Similar Documents

Publication Publication Date Title
JP2023145544A5 (https=)
US20230212143A9 (en) Prmt5 inhibitor compounds
EP1353662B1 (en) Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
AU2002305952B2 (en) Pharmaceutical combinations
JP2005525323A5 (https=)
BR112020019325A2 (pt) Método de tratamento de doença fibrótica
EP1714960B1 (en) Novel therapeutic agent for amyotrophic lateral sclerosis (als) or disease attributable to als
BR112019026474A2 (pt) compostos para tratar tnbc
JP2007262082A (ja) 多発性硬化症の処置のためのリルゾールの使用
RU2763525C2 (ru) Комбинированная терапия для лечения легочной гипертензии
SK7502002A3 (en) Pharmaceutical combinations
HUT52091A (en) Process for producing new 2,3,4-substituted imidazoles and 3,4,5-substituted 1,2,5-substituted 1,2,4-triazoles and pharmaceutical compositions comprising same
US20040122008A1 (en) Treatment of pain by inhibition of p38 MAP kinase
US20240100041A1 (en) Compositions and methods for treating inflammatory bowel disease using ccr9 inhibitor and anti-il-23 blocking antibodies
JP2021506975A5 (https=)
JP2002534477A (ja) メラガトランの新規使用
JP2023502745A5 (https=)
JP2003513037A (ja) β２（β２）アドレノレセプターアゴニストとロイコトリエンアンタゴニストを含む新規組合せ
CN111670188B (zh) 用于治疗纤维化的化合物和组合物
JP2003522121A (ja) 多発性硬化症の処置のためのリルゾールの使用
US3317383A (en) Decongestive compositions and method
US20090022686A1 (en) Pharmaceutical compositions for the treatment of systemic inflammatory response syndrome
AU2008225372B2 (en) A medicament for treating chronic obstructive pulmonary disease
CZ290381B6 (cs) Farmaceutický přípravek
JP2024516730A5 (https=)